These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 17020652

  • 1. [Selected matrix metalloproteinases (MMP-2, MMP-9) in obese children and adolescents].
    Głowińska-Olszewska B, Urban M, Florys B.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):179-83. PubMed ID: 17020652
    [Abstract] [Full Text] [Related]

  • 2. Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents.
    Głowińska-Olszewska B, Urban M.
    Metabolism; 2007 Jun; 56(6):799-805. PubMed ID: 17512313
    [Abstract] [Full Text] [Related]

  • 3. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
    Głowińska B, Urban M, Peczyńska J, Florys B.
    Przegl Lek; 2004 Jun; 61(9):935-9. PubMed ID: 15803902
    [Abstract] [Full Text] [Related]

  • 4. [Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes].
    Florys B, Głowińska B, Urban M, Peczyńska J.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Jun; 12(3):184-9. PubMed ID: 17020653
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.
    Kosmala W, Plaksej R, Przewlocka-Kosmala M, Kuliczkowska-Plaksej J, Bednarek-Tupikowska G, Mazurek W.
    Int J Obes (Lond); 2008 May; 32(5):763-71. PubMed ID: 18197181
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Matrix metalloproteinase-2 and -9 levels in obese patients.
    Derosa G, Ferrari I, D'Angelo A, Tinelli C, Salvadeo SA, Ciccarelli L, Piccinni MN, Gravina A, Ramondetti F, Maffioli P, Cicero AF.
    Endothelium; 2008 May; 15(4):219-24. PubMed ID: 18663625
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus.
    Derosa G, Avanzini MA, Geroldi D, Fogari R, Lorini R, De Silvestri A, Tinelli C, Rondini G, d'Annunzio G.
    Diabetes Res Clin Pract; 2005 Nov; 70(2):119-25. PubMed ID: 16188574
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients.
    Huang CY, Wu TC, Lin WT, Leu HB, Lin CP, Lin SJ, Chen JW.
    Eur J Clin Invest; 2006 Feb; 36(2):76-84. PubMed ID: 16436088
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.
    Derosa G, D'Angelo A, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo S, Montagna L, Gravina A, Ferrari I, Galli S, Paniga S, Tinelli C, Cicero AF.
    Endothelium; 2006 Feb; 13(3):227-31. PubMed ID: 16840178
    [Abstract] [Full Text] [Related]

  • 17. [Selected adhesion molecules: sICAM-1 and sVCAM-1 as markers of endothelial dysfunction in diabetic children and adolescence].
    Głowińska B, Urban M, Peczyńska J, Szczepańska-Kostro J.
    Pol Merkur Lekarski; 2003 Mar; 14(81):205-9. PubMed ID: 12914095
    [Abstract] [Full Text] [Related]

  • 18. Plasma matrix metalloproteinase-9 levels and blood pressure in short children born small for gestational age and effects of growth hormone treatment.
    Willemsen RH, van Dijk M, de Kort SW, van Toorenenbergen AW, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):264-8. PubMed ID: 18284641
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension.
    Zervoudaki A, Economou E, Pitsavos C, Vasiliadou K, Aggeli C, Tsioufis K, Toutouza M, Stefanadis C, Toutouzas P.
    Am J Hypertens; 2004 Mar; 17(3):273-6. PubMed ID: 15001203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.